ATC Group: A06AD11 Lactulose

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A06AD11 in the ATC hierarchy

Level	Code	Title
`1`	A	Alimentary tract and metabolism
`2`	A06	Laxatives
`3`	A06A	Laxatives
`4`	A06AD	Osmotically acting laxatives
`5`	A06AD11	Lactulose

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	6.7 g

Active ingredients in A06AD11

Active Ingredient
Lactulose
Lactulose is a synthetic disaccharide which is metabolised by gastro-intestinal bacterial flora to low molecular weight acids (chiefly lactic and acetic acids). There is no endogenous metabolising enzyme in the human gut. Its mode of action in constipation is as an osmotic agent producing soft stools.

Related product monographs

Document	Type	Information Source
CONSTULOSE Oral solution	MPI, US: SPL/Old	FDA, National Drug Code (US)
DUPHALAC Oral solution	MPI, EU: SmPC	Health Products Regulatory Authority (IE)
LACTECON Oral solution	MPI, EU: SmPC	Health Products Regulatory Authority (IE)
LAEVOLAC Oral solution	MPI, EU: SmPC	Health Products Regulatory Authority (IE)